Resources

  • Clear All
Past Presentation
HCV in Pregnant Women: How the Opioid Crisis is Changing the Landscape | September 26, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv and children  #hcv and opioids  #hcv and pregnancy  #maternal child health  #opioids  

Dr. Francheska Sevy Gurule, a Maternal Child Health Fellow at the University of New Mexico, Department of Family and Community Medicine, presents on the impact the opioid crisis has had on the prevalence of HCV in pregnant women.

Date added: 09/26/18

Past Presentation
Interdisciplinary Care at Shoshone-Bannock | September 13, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #interdisciplinary care  #shoshone-bannock  

A brief overview of healthcare services offered at the Shoshone-Bannock Fort Hall IHS facility and the Shoshone-Bannock Department of Tribal Health and Human Services, as well as the design and impact of a quality improvement study conducted by the Tribe.

Date added: 09/13/18

Past Presentation
Long Term Follow-Up After HCV Treatment | September 11, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv treatment  #reinfection prevention  #treatment follow-up  

Dr. Paulina Deming, an Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the needed follow-up for patients with and without cirrhosis who have completed HCV treatment, including counseling on lifestyle changes to prevent reinfection.

Date added: 09/11/18

Past Presentation
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | Addressing Starting an HCV Clinic at Crow/Northern Cheyenne | August 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #elastography  #fibroscan  #hcv elimination  #lummi  

Dr. Justin Iwasaki, the Executive Medical Director at Lummi Tribal Health Center (LTHC), discusses the creation and design considerations of the HCV Elimination Program at the LTHC, and then he provides an overview of FibroScan technology. Also, a team from ...

Date added: 08/25/18

Past Presentation
Addressing Transient Elastography (FibroScan): Integrating with HCV Care | August 14, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #elastography  #fibroscan  #liver disease  

Dr. Youssef Barbour, a Liver Specialist at the Alaska Native Medical Center, provides an overview of transient elastography (FibroScan) and the role that it can play in treating liver disease.

Date added: 08/14/18

Past Presentation
Diabetic Retinopathy and Neuropathy: 2018 Clinical Practice Guidelines | August 9, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #clinical practice guidlines  #diabetic neuropathy  #diabetic retinopathy  

In this presentation, Dr. Richard Arakaki, professor at the University of Hawaii John A. Burns School of Medicine, shares information about 2018 clinical practice guidelines for diabetic retinopathy and neuropathy.

Date added: 08/9/18

Past Presentation
Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Idaho, Oregon & Washington) | July 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #barriers to care  #hcv treatment  #idaho  #oregon  #washington  

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People's Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the states of Idaho, Oregon and Washington in their ability ...

Date added: 07/25/18

Past Presentation
Prevention of Macrovascular Complications of Diabetes | July 12, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Diabetes ECHO Program  

Keywords: #macrovascular complications  #risk reduction  

Dr. Matthew Bouchonville, Assistant Professor at the Department of Endocrinology at the University of New Mexico, shares information about risk factors for macrovascular complications associated with diabetes. Dr. Bouchonville also offers insight into the promising outcomes associated with multifactorial risk ...

Date added: 07/12/18

Past Presentation
Addressing Barriers to Hepatitis C Care Faced By Individuals Who Use Drugs (Alaska) | July 10, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #alaska  #hcv treatment  

In these slides, Dr. Tina Broder from the National Viral Reduction Alliance, Dr. Vanessa McMahan from the People’s Harm Reduction Alliance, and Louise Vincent from the Urban Survivors Union, grade the state of Alaska in its ability to provide hepatitis ...

Date added: 07/10/18

Past Presentation
HCV Treatment in People Receiving MAT | June 25, 2018

Type: Past Presentation  

Audience: Clinical  

Program: Hepatitis C  

Keywords: #hcv treatment  #mat  #medication assisted treatment  

In these slides, Dr. Jacob Kesner, an Infectious Diseases Pharmacist at Lovelace Medical Center, discusses the relationship between people receiving MAT and HCV treatment, shares his rationale for providing HCV treatment to people receiving MAT and offers best practices for ...

Date added: 06/25/18